Organon & Co (OGN) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Interested In Organon's (NYSE:OGN) Upcoming US$0.28 Dividend? You Have Four Days Left
Simply Wall StAug 11 09:40 ET
Organon & Co. (NYSE:OGN) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Simply Wall StAug 10 09:10 ET
Organon & Co Snaps Six Days of Losses
Seeking AlphaAug 7 16:20 ET
Organon & Co | 10-Q: Q2 2024 Earnings Report
SEC announcementAug 7 08:11 ET · Announcements
Barclays Maintains Organon & Co(OGN.US) With Buy Rating, Maintains Target Price $26
Moomoo NewsAug 7 04:32 ET · Ratings
Organon & Co To Go Ex-Dividend On August 16th, 2024 With 0.28 USD Dividend Per Share
Moomoo NewsAug 6 19:40 ET

Comments

whqqq

Jul 29 21:17

Cramer’s Lightning Round: Do not sell Constellation Energy

$Bank of America (BAC.US)$ : ”...You buy some right here, you buy some maybe if it breaks 40. I think this company is selling very inexpensively, and it’s a good one.”
$Illumina (ILMN.US)$ : “No. No Illumina. I like Danaher.”
$Constellation Energy (CEG.US)$ : “This is a solar play that is a very good company. It’s up a huge amount versus a lot of other stocks...I think you buy some, please hold on to it, do not sell it.”
$Meta Platforms (META.US)$ : “I thin...

https://www.youtube.com/watch?v=X4PV1Nqu1QU

From YouTube

3

1

Moomoo AI

Apr 6 07:51

Organon's low P/E ratio is due to its predicted growth being less than the broader market. Shareholders accept this as they anticipate future earnings won't bring any pleasant surprises. The share price is unlikely to rise significantly soon under these conditions.

Organon & Co.'s (NYSE:OGN) Earnings Are Not Doing Enough For Some Investors

4

Moomoo AI

Feb 18 17:32

Analysts show increased negativity towards the business following recent results, reflected in a minor decrease in next year's EPS estimates. Despite predicted earnings decline, Organon's valuation is not expected to be significantly affected, but growth is anticipated to lag behind the industry.

Organon & Co. Just Beat EPS By 70%: Here's What Analysts Think Will Happen Next

1

Moomoo AI

Feb 14 11:44

Seeking Alpha analysts are growing more bullish on the Merck spinoff, despite Wall Street's neutral stance. Analysts Leo Nelissen and Gen Alpha highlight OGN's attractive yield as a reason for their Buy ratings.

Organon Gaining Momentum Ahead of Q4 Earnings

1

Meticulous Trader

Nov 17, 2023 11:57

$Organon & Co (OGN.US)$ 📈

1

OGN Organon & Co

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target